New hope for advanced colon cancer: experimental drug combo enters key trial
NCT ID NCT07462143
First seen Mar 11, 2026 · Last updated May 21, 2026 · Updated 11 times
Summary
This study tests whether a new drug called RC148, when combined with chemotherapy, works better than the current standard treatment (bevacizumab plus chemo) for people with advanced colorectal cancer that cannot be removed by surgery. About 80 adults aged 18-75 with measurable tumors will take part. The main goal is to see how many patients' tumors shrink significantly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL (COLON OR RECTAL) CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
RECRUITINGWuxi, Jiangsu, China
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Beijing Friendship Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, China
-
Chongqing Cancer Hospital
RECRUITINGChongqing, Chongqing Municipality, China
-
Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, China
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanjing, Guangxi, China
-
Jiangsu Cancer Hospital
RECRUITINGNanjing, Jiangsu, China
-
Meizhou People's Hospital
RECRUITINGMeizhou, Guangdong, China
-
People's Hospital of Tianjin
RECRUITINGTianjin, Tianjin Municipality, China
-
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, China
-
Shanxi Cancer Hospital
RECRUITINGTaiyuan, Shanxi, China
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
-
The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital
RECRUITINGShijiazhuang, Hebei, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, China
-
The first hospital of Jilin University
RECRUITINGChangchun, Jilin, China
-
Tongji Medical College of Huazhong University of Science &Technology
RECRUITINGWuhan, Hubei, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, China
-
Yunnan Cancer Hospital
RECRUITINGKunming, Yunnan, China
Conditions
Explore the condition pages connected to this study.